BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND APOBEC3B, ARP4, 9582, ENSG00000179750, DJ742C19_2, _phorbolin 3_, PHRBNL, FLJ21201, Q9UH17, bK150C2_2, APOBEC1L, ARCD3 AND Treatment
26977 results:

  • 1. Characterizing colon lipomas: Insights from a retrospective analysis of clinical presentation and management strategies.
    Uygur FA; Kuloğlu E; Aydin G; Muhtaroğlu A; Dülger AC
    Medicine (Baltimore); 2024 May; 103(21):e38287. PubMed ID: 38787996
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Advances of CAR-T cell therapy in treating colorectal cancer].
    Chao Z; Liu W; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1365-1379. PubMed ID: 38783803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A combinatorial MRI sequence-based radiomics model for preoperative prediction of microsatellite instability status in rectal cancer.
    Xing X; Li D; Peng J; Shu Z; Zhang Y; Song Q
    Sci Rep; 2024 May; 14(1):11760. PubMed ID: 38783014
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Actively targeted photodynamic therapy in multicellular colorectal cancer spheroids via functionalised gold nanoparticles.
    Simelane NWN; Abrahamse H
    Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):309-320. PubMed ID: 38781462
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
    Adames A; O'Brien DR; Kelly AR; Saltz LB; Garcia-Aguilar J; Zinovoy M; Williams V; Wu A; Reyngold M; Hajj C; Crane C; Cercek A; Smith JJ; Markova A; Cuaron J; McCann P; Romesser PB
    Int J Colorectal Dis; 2024 May; 39(1):75. PubMed ID: 38780794
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Epidemiological characteristics of early-onset colorectal cancer: a prospective cohort study from a single center].
    Jin T; Zhu YS; Liu CC; Xu X; Lu W; Xiao Q; Ding KF; Zheng S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):457-463. PubMed ID: 38778685
    [No Abstract]    [Full Text] [Related]  

  • 7. [Anal canal cancer : epidemiology, work-up, treatment and perspective].
    Lallemand F; Troisfontaine F; Lamande M; Coucke P
    Rev Med Liege; 2024 May; 79(S1):45-48. PubMed ID: 38778649
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RUNX1-induced upregulation of PTGS2 enhances cell growth, migration and invasion in colorectal cancer cells.
    Zheng W; Guo Y; Kahar A; Bai J; Zhu Q; Huang X; Li Y; Xu B; Jia X; Wu G; Zhang C; Zhu Y
    Sci Rep; 2024 May; 14(1):11670. PubMed ID: 38778047
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis.
    Wibowo AA; Willyanto NA
    Clin Nutr ESPEN; 2024 Jun; 61():322-332. PubMed ID: 38777451
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characterization of the effects of thymol derivatives on colorectal cancer spheroids.
    Blažíčková M; Bučková M; Kozics K
    Neoplasma; 2024 Apr; 71(2):193-200. PubMed ID: 38766852
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database.
    Yang L; Yu L; Zhou Q; Liu L; Shen N; Li N
    Sci Rep; 2024 May; 14(1):11426. PubMed ID: 38763982
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
    Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
    Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Upregulation of Immune checkpoint PD-L1 in Colon cancer cell lines and activation of T cells by Leuconostoc mesenteroides.
    Altves S; Guclu E; Yetisgin E; Bilecen K; Vural H
    World J Microbiol Biotechnol; 2024 May; 40(7):204. PubMed ID: 38755413
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathologic Profile and treatment Outcomes of colorectal cancer in Young Adults: A Multicenter Study From India.
    Sehrawat A; Khanna M; Kayal S; Sundriyal D; Tiwari S; Cyriac S; Ravishankaran P; Raphael J; Mathew D; Panda SS; Moharana L; Mohanty SS; Mohanty SS; Philips A; Jain D; Jeyaraj P; David PH; Patil J; Saju SV; Rathnam K; Sharma N; Dheva K; Jinkala SR; Raja K; Penumadu P; Ganesan P
    JCO Glob Oncol; 2024 May; 10():e2300225. PubMed ID: 38754051
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Gene mutation profiling in microsatellite instability colorectal cancer and its association with the efficacy of immunotherapy: A retrospective study.
    Liu Y; Cui K; Ma W
    Cancer Med; 2024 May; 13(9):e6910. PubMed ID: 38746969
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Quality of Life in Patients Undergoing Emergency Surgery for Complex colorectal cancer: Protocol and Piloting of the Surgical Utilization and Recovery Patterns for Advanced Stage colorectal cancer Study.
    Ciubotaru C; Poenaru RC; Beuran M; Pătraşcu T; Turculeţ CȘ; Constantinescu G; Hostiuc S; Moldoveanu A; Negoi I
    Chirurgia (Bucur); 2024 Apr; 119(2):156-170. PubMed ID: 38743829
    [No Abstract]    [Full Text] [Related]  

  • 18. An inflammation-related subtype classification for analyzing tumor microenvironment and clinical prognosis in colorectal cancer.
    Pei J; Gao Y; Wu A
    Front Immunol; 2024; 15():1369726. PubMed ID: 38742117
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Projected estimates of cancer in Canada in 2024.
    Brenner DR; Gillis J; Demers AA; Ellison LF; Billette JM; Zhang SX; Liu JL; Woods RR; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D;
    CMAJ; 2024 May; 196(18):E615-E623. PubMed ID: 38740416
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Taking SCFAs produced by Lactobacillus reuteri orally reshapes gut microbiota and elicits antitumor responses.
    Li N; Niu L; Liu Y; Wang Y; Su X; Xu C; Sun Z; Guo H; Gong J; Shen S
    J Nanobiotechnology; 2024 May; 22(1):241. PubMed ID: 38735933
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1349.